Corindus to Present at Upcoming November 2018 Healthcare Conferences

Nov. 7, 2018 21:30 UTC

WALTHAM, Mass.--(BUSINESS WIRE)-- Corindus Vascular Robotics, Inc. (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that management will present at two investor conferences in November as follows:

Conference:     Stifel 2018 Healthcare Conference
Date:     Wednesday, November 14, 2018
Time:     12:30 p.m. Eastern Standard Time
Location:     Lotte New York Palace Hotel, NYC
Presenter:     David Long, Chief Financial Officer

Conference:     Canaccord Genuity Medical Technologies & Diagnostics Forum
Date:     Thursday, November 15, 2018
Time:     2:30 p.m. Eastern Standard Time
Location:     Westin Grand Central Hotel, NYC
Presenters:     Mark Toland, President and Chief Executive Officer and David Long, Chief Financial Officer

The presentations will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the company’s website at, under the News & Events Section.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The Company's CorPath® System is the first FDA-cleared medical device to bring robotic precision to percutaneous coronary and vascular procedures. During the procedure, the interventionalist sits at a radiation-shielded workstation to advance guide catheters, stents, and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. CorPath GRX is the second generation robotic-assisted technology offering enhancements to the platform by adding important key upgrades that increase precision, improve workflow, and extend the capabilities and range of procedures that can be performed robotically. With the CorPath System, Corindus Vascular Robotics brings robotic precision to interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement during manual procedures. For additional information, visit, and follow @CorindusInc.



Trevi Communications
Media Contacts:
Lisa Murray, 978-750-0333 ext. 2
In-Site Communications, Inc.
Investor Contact:
Lisa Wilson, 917-543-9932



Source: Corindus Vascular Robotics, Inc.

Back to news